We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Patient's Stem Cells Used To Create New Trachea

By LabMedica International staff writers
Posted on 09 Dec 2008
In a revolutionary development, an international medical effort has succeeded in providing a critically ill, 30-year-old Colombian woman with a new tracheal graft. More...
The new organ was constructed by Italian and British scientists, while the reconstructive surgery took place in Spain. A 7-cm long portion of trachea was harvested from a deceased patient, cleansed of all its tissue, and then modified with the woman's own stem cells.

The stem cells were harvested from the woman's own spinal cord, and grown in the laboratory at the University of Bristol (UB; UK). "Surgeons can now start to see and understand the very real potential for adult stem cells and tissue engineering to radically improve their ability to treat patients. We believe this success has proved that we are on the verge of a new age in surgical care,” said UB surgery professor, Dr. Martin Birchall, one of the members of the team that grew the cells.

The next step, for the hospital in Barcelona, Spain, was to send the harvested windpipe to University of Padua (Italy), where a team of researchers, led by Dr. Maria Teresa Conconi, used detergents and a variety of enzymes to remove all existing cells from the trachea. After approximately six weeks, all that was left was a scaffold, strong enough to sustain the implantation of other cells on top of it.

At the same time, Bristol scientists grew the cells in the laboratory, forcing them to develop as new cartilage cells, the type that can usually be found in the windpipe. When the graft was complete, they sent it to Italy again, but this time at the Polytechnic of Milan. There, a bioreactor fused the scaffold and the new cells together, after four days of incubation. It took from March to June 2008 to complete this troublesome task, but, finally, surgeon Dr. Paolo Macchiarini, at the Hospital Clinic (Barcelona, Spain) managed to perform the surgery, offering the patient, who could not use her left lung, a new chance. Now, more than five months later, the transplant is still healthy, and her body shows no signs of rejecting the new organ.

The study was published online November 19, 2008, in the journal The Lancet. "We think this represents a landmark and hope it will unlock the door for a safe and recipient-tailored transplantation of the airway in adults and children,” the authors reported in their study. "We hope that these future patients will no longer suffer the trauma of speech loss, severe shortness of breath, and limited social activities.”

Even more significantly, the procedure helps establish real evidence that new organs can be developed from a patient's stem cells. Moreover, this may lead to a groundbreaking new approach to developing replacement body parts.

Related Links:
University of Bristol
University of Padua
Hospital Clinic, Barcelona


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.